Literature DB >> 24922688

Histological growth pattern of and alpha-actinin-4 expression in thyroid cancer.

Nobuaki Tanaka1, Taku Yamashita2, Sohei Yamamoto3, Takeshi Matsunobu1, Hitoshi Tsuda3, Kazufumi Honda4, Tesshi Yamada4, Seiichi Tamai5, Akihiro Shiotani1.   

Abstract

AIM: To assess the clinicopathological significance of the histological growth pattern (HGP) and α-actinin-4 (ACTN4) expression in thyroid cancer. PATIENTS AND METHODS: We classified 83 thyroid cancer cases into infiltrative margin (IM) and pushing margin (PM) groups according to peripheral tumor margin contour and immunohistochemically determined ACTN4 expression. Correlations between clinical stage and clinicopathological characteristics were analyzed.
RESULTS: IM and high ACTN4 expression were observed in 39% and 49% of cancer cases, respectively. Higher clinical stage was significantly correlated with older age, higher T and N factor, preoperative recurrent laryngeal nerve paralysis (pre-RLNP), IM, and poor prognosis. Patients with stage IV disease had significantly poorer prognosis than those with stages I-III. On multivariate analysis, older age, pre-RLNP, and IM correlated with higher clinical stages. IM was significantly correlated with high ACTN4 expression.
CONCLUSION: IM, pre-RLNP, and ACTN4 expression could be novel indicators of tumor aggression and prognostic factors of thyroid cancer. Copyright
© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Thyroid; alpha-actinin-4; infiltrative margin; preoperative recurrent laryngeal nerve paralysis; pushing margin

Mesh:

Substances:

Year:  2014        PMID: 24922688

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  Sendai virus-mediated gene transfer of the c-myc suppressor far-upstream element-binding protein-interacting repressor suppresses head and neck cancer.

Authors:  N Tanaka; K Araki; D Mizokami; Y Miyagawa; T Yamashita; M Tomifuji; Y Ueda; M Inoue; K Matsushita; F Nomura; H Shimada; A Shiotani
Journal:  Gene Ther       Date:  2015-01-15       Impact factor: 5.250

Review 2.  Role of ACTN4 in Tumorigenesis, Metastasis, and EMT.

Authors:  Dmitri Tentler; Ekaterina Lomert; Ksenia Novitskaya; Nikolai A Barlev
Journal:  Cells       Date:  2019-11-13       Impact factor: 6.600

Review 3.  The mechanobiome: a goldmine for cancer therapeutics.

Authors:  Eleana Parajón; Alexandra Surcel; Douglas N Robinson
Journal:  Am J Physiol Cell Physiol       Date:  2020-11-11       Impact factor: 4.249

4.  Manganese superoxide dismutase promotes interaction of actin, S100A4 and Talin, and enhances rat gastric tumor cell invasion.

Authors:  Hiroko P Indo; Hirofumi Matsui; Jing Chen; Haining Zhu; Clare L Hawkins; Michael J Davies; Chontida Yarana; Daret K St Clair; Hideyuki J Majima
Journal:  J Clin Biochem Nutr       Date:  2015-05-22       Impact factor: 3.114

5.  The biological role of actinin-4 (ACTN4) in malignant phenotypes of cancer.

Authors:  Kazufumi Honda
Journal:  Cell Biosci       Date:  2015-08-18       Impact factor: 7.133

6.  Actinin-4 as a Diagnostic Biomarker in Serum of Breast Cancer Patients.

Authors:  Cheng Fang; Juan-Juan Li; Tong Deng; Bing-Hui Li; Pei-Liang Geng; Xian-Tao Zeng
Journal:  Med Sci Monit       Date:  2019-05-04

7.  Serum Actinin-4 Levels as a Potential Diagnostic and Prognostic Marker in Cervical Cancer.

Authors:  Xigui Ma; Huiying Xue; Jixiang Zhong; Bo Feng; Yanghua Zuo
Journal:  Dis Markers       Date:  2020-08-14       Impact factor: 3.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.